PP-240: LONG TERM CLINICAL OUTCOMES OF DRUG-ELUTING STENT AND BRACHYTHERAPY USE IN CORONARY ARTERY DISEASE: FIVE YEARS OF FOLLOW UP
Orhan Doğdu(Erciyes University), E. Basar, Nihat Kalay(Erciyes University), Özgür Günebakmaz(Erciyes University), Mahmut Akpek, Mehmet Güngör Kaya(Erciyes University), Mikail Yarlıoğlueş(Erciyes University), Şaban Keleşoğlu(Erciyes University)
Cited by 0
Related Papers
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
|Journal of the American College of Cardiology|2006|715
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
|International Journal of Cardiology|2012|325
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
|European Journal of Heart Failure|2014|259
Cardiovascular Effects of Carbon Monoxide Poisoning
|The American Journal of Cardiology|2006|141